Middle East and Africa In-Vitro Diagnostics Market – Growth & Forecast (2024 – 2032)

In-Vitro diagnostics are the tests that protect our blood supply, monitor the level of drugs we are given and provide information to assist diagnostics & treatments. This diagnosis will provide the information about the way the body is functioning and the state of health be obtained by evaluating biological specimens such as blood, tissues, urine and other body fluids taken directly from the human body. The benefits concerning in-vitro diagnostics include improved patient outcome, reduced healthcare spending, protecting consumer safety, more efficient and others.

The Middle East and Africa In-Vitro Diagnostics Market Size & Growth:

The Middle East and Africa In-Vitro Diagnostics Market size are projected to reach approximately $ XX Billion by the end of 2024 with a CAGR close to X% from $XX Billion in 2018 during the forecast timeline 2018-2024. The Key factors that drive the growth of the market include increasing adoption of point-of-care testing, growing number of private diagnostic centres, increasing government expenditure on healthcare, rising incidence of chronic lifestyles & infectious diseases, growing adoption of new technologies and others. Major restraints for the In-Vitro Diagnostics include rising healthcare costs, unclear reimbursement policies, stringent regularity policies and others.

Innovations and developments in in-vitro diagnostics allow the individuals to perform pregnancy tests easily from home by placing urine samples on test sticks. These tests are accurate, less time consuming and cost-efficient. Increase in incidence of chronic diseases and rising investments for the advancement of healthcare sector by the government along with growing number of public and private diagnostic centres are key factors driving the market growth of in-vitro diagnostics market.

The Middle East and Africa In-Vitro Diagnostics Market Share:

Various parameters divided the Middle East and Africa In-Vitro Diagnostics market. By the Technology, they are divided into immunodiagnostics, clinical chemistry, molecular diagnostics, haematology, clinical microbiology, coagulation & hemostasis and other technologies. As the immunodiagnostics segment was again categorised into the rapid test, western blot, radioimmunoassay, and others.

The clinical chemistry segment was again categorised into the liver panel, electrolyte panel, thyroid function panel, basic metabolic panel and others. The molecular diagnostics segment was again categorised into microarray, hybridisation, DNA sequencing and others. Among them, Immunodiagnostics has the largest market share owing to the increasing demand for personalised medicines and growth in ageing population along with changes in demographics & lifestyles.

By product & Service, they are divided into instruments, reagents & kits, services and data management software. Among them, Reagents & Kits segment has accounted for largest market share and it also is the fastest growing market during the forecast period owing to raising a number of IVD tests performed and its increased accessibility towards wide-range of reagents.

By the Application, they are divided into cardiology, infectious diseases, diabetes, oncology/cancer, autoimmune diseases, HIV/AIDS, drug testing and other applications. Among them, infectious diseases has the largest market share owing to rise in the incidences of various disorders such as tuberculosis, hepatitis and hospital-acquired infections fueled the demand for IVD techniques whereas oncology/cancer segment is expected to register highest CAGR during the forecast period owing to the growing incidence of cancer form that simulates the early detection of the disease.

By the End-User, they are divided into hospitals, point-of-care testing, laboratories, academic institutions, patient self-testing and others. Among them, laboratories have the largest market share owing to unavailability of complex tests in hospitals and commercial clinics. By Geography, Africa has the largest market share owing to increasing growth towards infectious disease diagnostics in that region.

The Middle East and Africa In-Vitro Diagnostics Market Trends:

• Illumina acquired KingMed Diagnostics to develop next-generation sequencing technologies and to provide point-to-deliver precision medicine for patients.
• DxONE has invented an automated end-to-end software solution which increases operational efficiency by automatically recording, tracking and monitoring the laboratories consumables.

The Middle East and Africa In-Vitro Diagnostics Market Research Reports:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.

Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

Identify the latest developments, market shares and strategies that are employed by the major market players, such as

• Abott Laboratories, INC
• Biomerieux SA
• Beckton, Dickinson and Company
• Bio-Rad Laboratories, INC
• Alere, INC

Along with these companies, there were many other companies considered/cited in the report while analysing the Middle East and Africa In-Vitro Diagnostics market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.